Jacobio Pharmaceuticals Group Co., Ltd. (Stock code: 1167) has scheduled a board meeting on Tuesday, March 10, 2026. The primary agenda is to review and approve the annual results for the fiscal year ended December 31, 2025, along with other general business matters.
According to the announcement dated February 26, 2026, the board is led by Chairman and Executive Director, Dr. Yinxiang Wang, with additional executive, non-executive, and independent non-executive directors supporting the meeting to ensure comprehensive decision-making.